STRO vs WMB · rev $62.0M vs P/E 31, rev $11.95B
Sutro Biopharma (STRO) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported WMB revenue for 2025-12-31 was $11.95B. Net income was $2.62B. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
STRO currently screens at market cap $470.8M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the STRO and WMB stock pages for the full models.
Not investment advice.